Susquehanna International Group
CURE icon

Susquehanna International Group’s Direxion Daily Healthcare Bull 3X ETF CURE Stock Holding History

Susquehanna International Group’s Portfolio CURE Stock Details CURE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.55M Sell
27,900
-32,500
-54% -$3.53M ﹤0.01% 5617
2025
Q4 		$6.74M Sell
60,400
-34,100
-36% -$3.49M ﹤0.01% 3583
2025
Q3 		$7.89M Buy
94,500
+54,300
+135% +$4.23M ﹤0.01% 3358
2025
Q2 		$3.17M Sell
40,200
-1,700
-4% -$137K ﹤0.01% 4853
2025
Q1 		$4.47M Buy
41,900
+21,700
+107% +$2.31M ﹤0.01% 3870
2024
Q4 		$1.86M Buy
20,200
+9,700
+92% +$1.09M ﹤0.01% 5480
2024
Q3 		$1.4M Sell
10,500
-1,400
-12% -$180K ﹤0.01% 6062
2024
Q2 		$1.39M Sell
11,900
-5,900
-33% -$665K ﹤0.01% 5831
2024
Q1 		$2.23M Sell
17,800
-1,100
-6% -$128K ﹤0.01% 5068
2023
Q4 		$1.92M Buy
18,900
+10,400
+122% +$932K ﹤0.01% 5441
2023
Q3 		$753K Sell
8,500
-5,900
-41% -$580K ﹤0.01% 7281
2023
Q2 		$1.44M Sell
14,400
-9,200
-39% -$915K ﹤0.01% 5855
2023
Q1 		$2.27M Sell
23,600
-19,600
-45% -$1.97M ﹤0.01% 4872
2022
Q4 		$4.96M Buy
43,200
+7,600
+21% +$822K ﹤0.01% 3244
2022
Q3 		$3.01M Buy
35,600
+14,400
+68% +$1.49M ﹤0.01% 4087
2022
Q2 		$2.19M Sell
21,200
-4,100
-16% -$462K ﹤0.01% 4717
2022
Q1 		$3.3M Sell
25,300
-17,300
-41% -$2.06M ﹤0.01% 4445
2021
Q4 		$6.18M Buy
42,600
+1,700
+4% +$206K ﹤0.01% 3403
2021
Q3 		$4.39M Hold
40,900
– – ﹤0.01% 4196
2021
Q2 		$4.28M Buy
40,900
+12,500
+44% +$1.2M ﹤0.01% 4315
2021
Q1 		$2.37M Buy
28,400
+6,700
+31% +$540K ﹤0.01% 5500
2020
Q4 		$1.67M Buy
21,700
+1,800
+9% +$124K ﹤0.01% 5493
2020
Q3 		$1.25M Buy
19,900
+4,900
+33% +$308K ﹤0.01% 5575
2020
Q2 		$815K Sell
15,000
-9,000
-38% -$478K ﹤0.01% 6350
2020
Q1 		$956K Sell
24,000
-31,500
-57% -$1.99M ﹤0.01% 5518
2019
Q4 		$4.09M Buy
55,500
+36,300
+189% +$2.22M ﹤0.01% 3258
2019
Q3 		$971K Sell
19,200
-14,800
-44% -$785K ﹤0.01% 5753
2019
Q2 		$1.91M Sell
34,000
-60,300
-64% -$3.11M ﹤0.01% 4262
2019
Q1 		$5.24M Buy
94,300
+4,100
+5% +$218K ﹤0.01% 2395
2018
Q4 		$4.29M Buy
90,200
+69,100
+327% +$3.88M ﹤0.01% 2465
2018
Q3 		$1.41M Buy
21,100
+9,300
+79% +$532K ﹤0.01% 4599
2018
Q2 		$535K Sell
11,800
-2,800
-19% -$125K ﹤0.01% 6647
2018
Q1 		$629K Sell
14,600
-16,900
-54% -$849K ﹤0.01% 6180
2017
Q4 		$1.47M Buy
31,500
+21,100
+203% +$977K ﹤0.01% 4502
2017
Q3 		$473K Sell
10,400
-14,000
-57% -$604K ﹤0.01% 6614
2017
Q2 		$1.02M Sell
24,400
-600
-2% -$22.2K ﹤0.01% 5223
2017
Q1 		$862K Buy
25,000
+8,200
+49% +$267K ﹤0.01% 5444
2016
Q4 		$463K Sell
16,800
-13,700
-45% -$387K ﹤0.01% 7160
2016
Q3 		$973K Buy
30,500
+5,500
+22% +$187K ﹤0.01% 4859
2016
Q2 		$791K Buy
+25,000
New +$753K ﹤0.01% 5319
2016
Q1 		– Sell
-54,800
Closed -$1.83M – 9080
2015
Q4 		$1.83M Buy
54,800
+1,300
+2% +$41.1K ﹤0.01% 4224
2015
Q3 		$1.42M Buy
53,500
+12,500
+30% +$459K ﹤0.01% 4998
2015
Q2 		$1.61M Sell
41,000
-41,000
-50% -$1.42M ﹤0.01% 5172
2015
Q1 		$2.41M Buy
82,000
+3,000
+4% +$83.7K ﹤0.01% 3953
2014
Q4 		$1.97M Buy
79,000
+39,500
+100% +$928K ﹤0.01% 4494
2014
Q3 		$816K Sell
39,500
-4,500
-10% -$87.5K ﹤0.01% 6328
2014
Q2 		$788K Buy
+44,000
New +$709K ﹤0.01% 6557

Other funds holding CURE

GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
TCM
Traynor Capital Management Malvern, Pennsylvania $2.18B AUM 62.36% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
OBWG
Onyx Bridge Wealth Group Tarrytown, New York $1.11B AUM 24.65% 1-Year Est. Return
PWPS
Pinnacle Wealth Planning Services Mansfield, Ohio $968M AUM 19.1% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Susquehanna International Group's CURE Position: Q1 2026 in Review

Susquehanna International Group reduced its Direxion Daily Healthcare Bull 3X ETF (CURE) stake by 46% in Q1 2026, selling an estimated $1.32M and leaving 14,032 shares worth $1.28M. The position accounts for ﹤0.01% of the portfolio, ranked #7257.

Susquehanna International Group first reported a position in CURE in Q2 2013 and has held it in 46 quarters since. The position peaked at $6.48M in Q1 2023. 15 funds tracked by Wall St. Rank hold CURE as of Q1 2026.

  • Susquehanna International Group held 14,032 shares of Direxion Daily Healthcare Bull 3X ETF worth $1.28M as of Q1 2026.
  • Susquehanna International Group sold 12,186 Direxion Daily Healthcare Bull 3X ETF shares in Q1 2026, an estimated $1.32M.
  • Direxion Daily Healthcare Bull 3X ETF made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7257 holding.
  • Susquehanna International Group first reported a position in Direxion Daily Healthcare Bull 3X ETF in Q2 2013 and has held it in 46 quarters since.
  • Susquehanna International Group's Direxion Daily Healthcare Bull 3X ETF position peaked at $6.48M in Q1 2023.
  • 15 funds tracked by Wall St. Rank held Direxion Daily Healthcare Bull 3X ETF as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.